Venture capital investments in the biotechnology industry dropped 6% year-to-year to almost $1.3 billion during the fourth quarter of 2012, but the number of deals grew by 8% to 135 during the period, according to the quarterly MoneyTree Report. For the entire year, biotech firms secured almost $4.1 billion, a decline of 15% from 2011, while the number of deals was fairly steady at 466.
Report: Biotech sector raised $1.3B in Q4 venture funding
SmartBrief Job Listings for Health Care
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Chief, Product Review Branch||
FDA/Center for Biologics Evaluation and Research
|Silver Spring, MD|
|Director of Clinical Research||
Regenesis Biomedical, Inc.